Publications by authors named "Mark T Leibowitz"

Claim this Profile
A
A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
Mark T Leibowitz, Cynthia A Zamora, Albert W Brzeczko, Jeffrey G Stark

Am J Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
Sandy A Furey, Steven G Hull, Mark T Leibowitz, Shyamalie Jayawardena, Thomas Roth

J Clin Sleep Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.
Carol Addy, Chris Assaid, David Hreniuk, Mark Stroh, Yang Xu, Mark T Leibowitz

J Clin Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similarity of insulin detemir pharmacokinetics, safety, and tolerability profiles in healthy caucasian and Japanese american subjects.
Stan S Jhee, William H Lyness, Patrick B Rojas, Mark T Leibowitz, Victoria Zarotsky

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis